MedPath

Motivational Interviewing for Smoking Cessation

Not Applicable
Conditions
Smoking Cessation
Interventions
Behavioral: Motivational interviewing
Registration Number
NCT02645838
Lead Sponsor
Capital Medical University
Brief Summary

The purpose of this study is to determine whether or not motivational interviewing is effective in smoking cessation at general practice setting in China.

Detailed Description

OBJECTIVES:

• To compare the effectiveness of motivational interviewing versus brief advice by conducting a randomized controlled trial in General Practice Setting in China.

OUTLINE:

This is a randomized controlled study. Patients are randomized to either the intervention arm or the control arm.

• Arm I (intervention): Patients will be given a 20 minutes personal talk in the family physician's office during the visit. The family physicians will determine the stage of change in smoking cessation (precontemplative, contemplative, action, maintenance and relapse) and use the motivational interviewing skills during the talk. The motivational interviewing skills include expressing empathy, developing discrepancy, rolling with resistance, supporting self efficacy. Up to six phone calls will be given to the patients during the follow-up, using the motivational interviewing skill.

• Arm II (control): Patients will receive brief advice for smoking cessation, lasting approximately 5 minutes. The risks of smoking and the advantages of quitting will be explained. The information provided during the talk will be standardized. No phone call will be given during the follow-up.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
210
Inclusion Criteria
  1. Between the ages of 18 and 80 years.
  2. Any person who replies "Yes" when asked "Do you smoke?".
  3. Agree to participate the trial and be followed for at least one year.
Exclusion Criteria
  1. With severe mental illness, serious drug dependent patients.
  2. Cannot understand conversation or cannot communicate, such as deafness or dementia.
  3. Cannot be followed up for one year, such as not likely survive for more than one year.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Motivational interviewing groupMotivational interviewing1. Structural motivational interviewing for one section (about 20 mins),provided by family physician 2. Follow-up telephone call,provided by family physician
Primary Outcome Measures
NameTimeMethod
1 week point prevalence abstinence (PPA)Self-reported PPA at 1 week follow-up

Validation: exhaled carbon monoxide (CO) (\< 10 ppm)

Secondary Outcome Measures
NameTimeMethod
1 month PPASelf-reported 7-day PPA at 1 month follow-up

Validation: exhaled CO (\< 10 ppm)

3 month PPASelf-reported 7-day PPA at 3 month follow-up

Validation: exhaled CO (\< 10 ppm)

6 month PPASelf-reported 7-day PPA at 6 month follow-up

Validation: exhaled CO (\< 10 ppm)

© Copyright 2025. All Rights Reserved by MedPath